Systematic review of statistical methods for safety data in malaria chemoprevention in pregnancy trials.

ABSTRACT: BACKGROUND:Drug safety assessments in clinical trials present unique analytical challenges. Some of these include adjusting for individual follow-up time, repeated measurements of multiple outcomes and missing data among others. Furthermore, pre-specifying appropriate analysis becomes difficult as some safety endpoints are unexpected. Although existing guidelines such as CONSORT encourage thorough reporting of adverse events (AEs) in clinical trials, they provide limited details for safety data analysis. The limited guidelines may influence suboptimal analysis by failing to account for some analysis challenges above. A typical example where such challenges exist are trials of anti-malarial drugs for malaria prevention during pregnancy. Lack of proper standardized evaluation of the safety o

SUBMITTER: Patson N 

PROVIDER: S-EPMC7085184 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature